29.06.2016
- The US federal government’s National Institutes of Health (NIH) has declined a petition from a public interest group to lower the price of a drug for advanced prostate cancer...
19.04.2016
- As the drug world’s M&A carousel continues to turn, British-Swedish drugmaker Astra Zeneca is being eyed as the latest contender to enter the race to buy US biotech firm Medivation...
18.06.2013
- Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired...
